Freeline Therapeutics Holdings PLC (DELISTED) (FRLN:DL)
6.49
USD |
NASDAQ |
Feb 16, 16:00
Freeline Therapeutics Holdings Price to Book Value : 0.9473 for Feb. 29, 2024
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Adaptimmune Therapeutics Plc | -- |
| Akari Therapeutics Plc | 0.4904 |
| Biodexa Pharmaceuticals Plc | -- |
| Verona Pharma Plc (DELISTED) | 33.23 |
| NuCana Plc | 0.4232 |
Price to Book Value Related Metrics
| Earnings Yield | -175.9% |